TuHURA Biosciences, Inc. (HURA) Financials

HURA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 31.7 million 13.2 million
March 31, 2026 29.7 million 6.5 million
Dec. 31, 2025 27.4 million 6.4 million
Sept. 30, 2025 25.7 million 8.9 million

HURA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -8.8 million 2.1 million
March 31, 2026 -4.5 million 2.8 million
Dec. 31, 2025 -5.6 million 2.0 million
Sept. 30, 2025 -11.1 million 1.6 million

HURA Net Income

No data available :(

HURA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 995977 192848 -
March 31, 2026 6.3 million - 250075
Dec. 31, 2025 3.6 million 303627 199041
Sept. 30, 2025 2.7 million - 84346

HURA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 64.0 million
March 31, 2026 60.0 million
Dec. 31, 2025 47.9 million
Sept. 30, 2025 50.7 million

HURA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 136978 6.6 million 2.1 million -
March 31, 2026 48847 5.2 million 2.3 million -
Dec. 31, 2025 27850 6.1 million 1.6 million -
Sept. 30, 2025 4 5.0 million 1.8 million -

HURA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 23472
Dec. 31, 2025 - -
Sept. 30, 2025 - 21000

HURA

Price: $2

52 week price:
0.41
3.90

Payout Ratio Range:
-0.03%
-0.02%

Earnings Per Share: -0.57 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 145.3 million

Links: